53 results
-
-
Survival Advantage with Total Intravenous Anesthesia in Cancer Surgery: Is This Confounded by Cancer Type and Stage?
Author(s) Pre Print Version Only. 12 month embargo on Post Print
-
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Author(s) Pre or Post Print Version
-
Improving primary care identification of familial breast cancer risk using proactive invitation and decision support.
Author(s) Pre or Post-Print Version Only
-
Future Research Priorities for Morbidity Control of Lymphedema.
-
Implementing TIMERS: the race against hard-to-heal wounds.
-
The shape of the CUP service at Royal Derby Hospital following the adoption of UKONS guidelines
Author(s) Pre or Post Print Version Only. No PDF
-
Long-term outcomes of biological mesh repair following extra levator abdominoperineal excision of the rectum: an observational study of 100 patients.
Author(s) Pre or Post Print Version Only
-
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma.
-
Lynch Syndrome Screening in Gynecological Cancers: Results of an International Survey with Recommendations for Uniform Reporting Terminology for Mismatch Repair Immunohistochemistry Results.
Author(s) Pre Print Version. 12 Month Embargo on Post
-
Lenalidomide before and after ASCT for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
-
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
-
Evaluation of a nudge intervention providing simple feedback to clinicians of the consequence of radiation exposure on demand for computed tomography: a controlled study.
Author(s) Pre Print Version. 12 Month Embargo on Post and PDF
-
A multicentre cross-sectional observational study of cancer multidisciplinary teams: Analysis of team decision making.
-
Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis.
-
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
-
Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer.
-
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Author(s) pre print version. 6 month embargo on post-print. No PDF
-
'Real-world' experience of colonic stents for obstructive colon cancer-feasible and safe with low morbidity and mortality
Author(s) Pre Print Version Only. 12 Month Embargo on Post Print. No PDF
-
Risk of colon cancer after acute uncomplicated diverticulitis: Is routine colonoscopy necessary?
Author(s) Pre Print Version Only. 12 Month Embargo on Post Print. No PDF